DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Dyskinesia
Dyskinesia
Tardive Dyskinesia
Neuroleptic Malignant Syndrome: a Case of Unknown Causation and Unique Clinical Course
Oromandibular Dyskinesia As the Initial Manifestation of Late-Onset Huntington Disease
The Paroxysmal Dyskinesias
Dyskinesia in Parkinson's Disease
Info Sheet on the Irreversible Side Effects of Psychotropic Medication
The Clinical Approach to Movement Disorders Wilson F
EXTRAPYRAMIDAL MOVEMENT DISORDERS (GENERAL) Mov1 (1)
Progressive Supranuclear Palsy: Diagnosis and Management
The Athetoid Syndrome. a Review of a Personal Series
A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia
Movement Disorders in Psychiatric Patients
A Physician's Guide to the Management of Huntington's Disease
Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias
Sensory Phenomena in Movement Disorders
Dyskinesia Impairment Scale (DIS)
Non-Commercial Use Only
Learn More About the MDS Progressive Supranuclear Palsy
Top View
Tardive Dyskinesia Tip Sheet
Tardive Dyskinesia
Tardive Dyskinesia (TD)
Utility of an Objective Dyskinesia Rating Scale for Parkinson's Disease
Hemifacial Spasm in Childhood Gabriel M
Pharmacological Therapy in Progressive Supranuclear Palsy
Motor Imagery in Facial Palsy Rehabilitation
Wearing Off and Involuntary Movements (Dyskinesia)
Persistent Hemiballismus with Lesions Outside the Subthalamic Nucleus Anthony E
Unified Dyskinesia Rating Scale (Udysrs)
Movement Disorders in Cerebrovascular Disease
A Treatment Guide to Parkinson's Disease
View Eposter
EMG Patterns in Abnormal Involuntary Movements Induced by Neuroleptics
Tardive Dyskinesia
Seven Cases of Successful Remission After Trial of Metoclopramide on Orofacial Dyskinesia of Stroke Patients: a Case Series
Medications for Huntington's Disease
Risk of Neuroleptic Malignant Syndrome with Vesicular Monoamine Transporter Inhibitors
Clinical Approach to Progressive Supranuclear Palsy
Hemiballism: Report of 25 Cases J Neurol Neurosurg Psychiatry: First Published As 10.1136/Jnnp.57.8.945 on 1 August 1994
TARDIVE DYSKINESIA Treatment with Metoclopramide Can Cause Tardive Dyskinesia, a Serious Movement Disorder That Is Often Irreversible
MSA Coalition 2014 1 Www
International Veterinary Canine Dyskinesia Task Force ECVN Consensus Statement: Terminology and Classification
Do You Have Dyskinesia Symptoms Or Motor Fluctuations Associated With
Blonanserin Induced Hypokinesia and Tardive Dyskinesia
Post-Stroke Dyskinesias Open Access to Scientific and Medical Research DOI
Patient Perception of Dyskinesia in Parkinson's Disease
Dyskinesia in Multiple System Atrophy and Progressive Supranuclear Palsy
NEURODEGENERATIVE ATYPICAL PARKINSONISM by Rachel Dolhun, MD, the Michael J
Tardive Dyskinesia and Dopamine Oxidation, Cumulative Effects
Dystonia in Multiple System Atrophy S M Boesch, G K Wenning, G Ransmayr, W Poewe
Stages of Huntingtons Disease and Treatment
Specialty Guideline Management
Understanding Dyskinesia
Caregiver Guide for Mid to Late Stage Huntington's Disease
Detecting Dyskinesia and Tremor in People with Parkinson’S Disease
Dynamical Learning and Tracking of Tremor and Dyskinesia from Wearable Sensors Bryan T
Progressive Supranuclear Palsy Expanding the Clinical and Genetic Spectrum
Chorea, Ataxia, Other Movement Disorders
NAVANE® Thiothixene Capsules
Vision Changes in Movement Disorders and Their Management
Tardive Dyskinesia Background Information: 1. the Likelihood Of
Drug-Induced Movement Disorders